2010 – Astex

2010 AACR_Immunomodulatory Activity of SGI-110

25 November 2010/in 2010, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

2010 AACR_Immunomodulatory Activity of SGI-110

2010 AACR J_S110 is Effective DNA Methylation Inhibitor In vivo and Reduces Tumor Growth

20 November 2010/in 2010, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

2010 AACR J_S110 is Effective DNA Methylation Inhibitor In vivo and Reduces Tumor Growth

2010 ASH_SGI-110 Preclinical, PK, DNA Methylation of Low Vol Subcutaneous Formulation

15 November 2010/in 2010, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

2010 ASH_SGI-110 Preclinical, PK, DNA Methylation of Low Vol Subcutaneous Formulation

2010 EORTC_Immunomodulatory activity of SGI-110

10 November 2010/in 2010, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

2010 EORTC_Immunomodulatory activity of SGI-110

2010 isBTC_Immunomodulatory activity of SGI-110

5 November 2010/in 2010, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

2010 isBTC_Immunomodulatory activity of SGI-110